Early Rat study, doesn't mean much really, dont really get the weak selling.
What I want to know is WHERE ARE THE PHASE 2 PLEX trial results, They are due !!!!
"PLEXOVAL II Clinical Trial Activities Complete Dosing of the 11 participants in PLEXOVAL II has completed and final follow-up medical appointments with all test subjects are also completed. No adverse events related to the treatment using Plexaris or the placebo were reported. The data will now be analysed by an independent third party with final results expected by around March 2021. “
- Forums
- ASX - By Stock
- TYP
- Ann: Preclinical Data from Osteoarthritis Animal Study
Ann: Preclinical Data from Osteoarthritis Animal Study, page-4
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.78M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $5.8K | 290K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 400039 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 280953 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 400039 | 0.018 |
3 | 574030 | 0.017 |
2 | 374065 | 0.016 |
1 | 70000 | 0.014 |
1 | 777777 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 280953 | 1 |
0.021 | 269485 | 2 |
0.022 | 528000 | 2 |
0.025 | 596153 | 5 |
0.027 | 300000 | 1 |
Last trade - 15.22pm 10/10/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online